TLDR Teradyne reported Q3 revenue of $769 million, beating estimates of $743.85 million by 3% Adjusted EPS reached $0.85, surpassing the $0.79 analyst consensus Q4 revenue guidance of $920 million to $1 billion crushes $816.64 million expectations Stock jumped 22% after hours on strong AI chip testing demand Michelle Turner replaces Sanjay Mehta as CFO [...] The post Teradyne (TER) Stock Soars After Blowout Earnings Report appeared first on Blockonomi.TLDR Teradyne reported Q3 revenue of $769 million, beating estimates of $743.85 million by 3% Adjusted EPS reached $0.85, surpassing the $0.79 analyst consensus Q4 revenue guidance of $920 million to $1 billion crushes $816.64 million expectations Stock jumped 22% after hours on strong AI chip testing demand Michelle Turner replaces Sanjay Mehta as CFO [...] The post Teradyne (TER) Stock Soars After Blowout Earnings Report appeared first on Blockonomi.

Teradyne (TER) Stock Soars After Blowout Earnings Report

2025/10/29 21:33
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Teradyne reported Q3 revenue of $769 million, beating estimates of $743.85 million by 3%
  • Adjusted EPS reached $0.85, surpassing the $0.79 analyst consensus
  • Q4 revenue guidance of $920 million to $1 billion crushes $816.64 million expectations
  • Stock jumped 22% after hours on strong AI chip testing demand
  • Michelle Turner replaces Sanjay Mehta as CFO starting November 3

Teradyne delivered a knockout third-quarter earnings report that sent shares soaring 22% in extended trading Tuesday. The semiconductor testing equipment maker crushed analyst expectations and issued guidance that has traders eyeing the stock’s best day ever.


TER Stock Card
Teradyne, Inc., TER

The company posted Q3 revenue of $769 million, up 4% from last year. That beat the Street’s call of $743.85 million.

Earnings per share hit $0.85 on an adjusted basis. Analysts were expecting $0.79.

AI Chip Testing Drives Growth

CEO Greg Smith credited the semiconductor test group for exceeding expectations. The division pushed both sales and profit to the high end of Q3 guidance.

System-on-a-Chip solutions for AI applications led the charge. Memory testing also contributed to the strong quarter.

The results reflect surging demand for testing equipment as chipmakers ramp up AI processor production. Quality control becomes critical with increasingly complex chip designs.

Teradyne now expects Q4 revenue between $920 million and $1 billion. That’s a 25% jump year-over-year and 27% higher than Q3.

The company forecast adjusted EPS of $1.20 to $1.46 for the current quarter. Both metrics sailed past consensus estimates of $816.64 million in revenue and $1.02 EPS.

CFO Transition Announced

Teradyne revealed that Sanjay Mehta will step down as CFO on November 3. Mehta has held the role since 2019.

Michelle Turner takes over as the new finance chief. Mehta will stay on as an executive advisor through 2026 to support capacity expansion efforts.

The leadership change comes as the North Reading, Massachusetts company scales up to meet semiconductor testing demand. Smith highlighted strong AI-related test demand across compute, networking, and memory segments heading into Q4.

Analysts have set an average price target of $143.81 for Teradyne stock, according to Koyfin data. That implies minimal downside from current levels.

The stock has gained 38.61% over the last three months as AI infrastructure spending accelerates. If after-hours gains hold Wednesday, Teradyne would notch its best single-day performance on record.

The post Teradyne (TER) Stock Soars After Blowout Earnings Report appeared first on Blockonomi.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unprecedented US Military Operation Shakes Middle East Security

Unprecedented US Military Operation Shakes Middle East Security

The post Unprecedented US Military Operation Shakes Middle East Security appeared on BitcoinEthereumNews.com. Trump Kharg Island Airstrike: Unprecedented US Military
Share
BitcoinEthereumNews2026/03/14 07:25
Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

The post Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme appeared on BitcoinEthereumNews.com. Michael Saylor has responded sharply
Share
BitcoinEthereumNews2026/03/14 07:22
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11